COVID-19 Antiviral Treatment

New treatment options for COVID-19 continue to emerge. Recently, two new oral antiviral treatment options have been granted Emergency Use Authorization (EUA) by the FDA. The EUA for PAXLOVID (nirmatrelvir/ritonavir) was issued on Dec. 22, 2021. The EUA for molnupiravir was issued on Dec. 23, 2021. These oral products are currently in very limited supply. To help guide the use of these medications, criteria for use (see links below) has been recommended by the Blue Chip COVID-19 Committee (an ad hoc committee of the NMMC Pharmacy and Therapeutics Committee) and approved by the NMMC Pharmacy and Therapeutics Committee. Locations where these treatment options are available, while supplies last, are listed below as well.

Paxlovid Criteria

Locations where NMHS currently has Paxlovid include:

• Amory Medical Clinic
• Barnes Crossing Urgent Care
• Belmont Family Medical Clinic
• Booneville Urgent Care
• Fulton Medical Clinic
• IMA-Tupelo
• Iuka Medical Clinic
• Med Serve
• Pontotoc Medical Clinic
• West Point Urgent Care
• West Tupelo Urgent Care

Molnupiravir Criteria

Locations where NMHS currently has Molnupiravir include:

• Amory Medical Clinic
• Amory Specialty Clinic
• Baldwyn Medical Clinic
• Barnes Crossing Testing Center
• Barnes Crossing Urgent Care
• Belmont Family Medical Clinic
• Booneville Urgent Care
• Calhoun County Medical Clinic
• Chickasaw Medical Clinic
• Ecru Medical Clinic
• Fulton Medical Clinic
• Hamilton (MS) Medical Clinic
• Eupora Family Medical Clinic
• Family Medicine Residency Center
• Iuka Medical Clinic
• IMA-Tupelo
• Kilmichael Family Medical Care
• Maben Medical Clinic
• Med Serve
• New Albany Medical Clinic
• Okolona Medical Clinic
• Oxford Medical Clinic
• Pontotoc Medical Clinic
• Saltillo Medical Clinic
• South Madison Medical Clinic
• West Point Urgent Care
• West Point Internal Medicine
• West Tupelo Urgent Care
• Verona Medical Clinic